Piramal Pharma Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '25 Jul 10, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	276,324	297,962	170,528	81,683	-	-
Market Cap Growth	74.73%	74.73%	108.77%	-	-	-
Enterprise Value	319,679	341,742	209,922	130,128	-	-
Last Close Price	207.85	224.50	128.81	66.78	-	-
PE Ratio	303.22	326.96	956.95	-	-	-
PS Ratio	3.02	3.26	2.09	1.15	-	-
PB Ratio	3.40	3.67	2.15	1.21	-	-
P/TBV Ratio	6.84	7.38	4.71	3.51	-	-
P/FCF Ratio	121.24	130.73	58.30	-	-	-
P/OCF Ratio	30.97	33.39	16.98	16.88	-	-
EV/Sales Ratio	3.49	3.73	2.57	1.84	-	-
EV/EBITDA Ratio	21.06	24.34	18.43	22.58	-	-
EV/EBIT Ratio	45.58	54.38	45.62	-	-	-
EV/FCF Ratio	140.26	149.94	71.77	-	-	-
Debt / Equity Ratio	0.60	0.60	0.60	0.83	0.62	0.54
Debt / EBITDA Ratio	3.36	3.36	4.00	9.21	3.63	2.30
Debt / FCF Ratio	21.31	21.31	16.10	-	-	-
Asset Turnover	0.59	0.59	0.55	0.52	0.57	-
Inventory Turnover	1.44	1.44	1.69	1.94	1.87	-
Quick Ratio	0.76	0.76	0.61	0.64	0.69	0.82
Current Ratio	1.54	1.54	1.25	1.26	1.34	1.47
Return on Equity (ROE)	1.14%	1.14%	0.24%	-2.77%	6.11%	-
Return on Assets (ROA)	2.54%	2.54%	1.93%	-0.20%	2.96%	-
Return on Capital (ROIC)	3.07%	3.07%	2.30%	-0.24%	3.60%	-
Return on Capital Employed (ROCE)	5.30%	5.30%	4.20%	-	5.70%	10.50%
Earnings Yield	0.33%	0.31%	0.10%	-2.28%	-	-
FCF Yield	0.82%	0.77%	1.71%	-5.89%	-	-
Dividend Yield	0.07%	0.06%	0.08%	-	-	-
Payout Ratio	15.88%	15.88%	-	-	13.30%	-
Buyback Yield / Dilution	-4.41%	-4.41%	-7.85%	-0.95%	-87.83%	-
Total Shareholder Return	-4.34%	-4.35%	-7.76%	-0.95%	-87.83%	-

Updated Jan 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.